Alan Huang
Consultant / Advisor presso Casdin Capital /Private Equity/
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Alan Huang is currently an Advisor at Casdin Capital since 2021.
Prior to this, he was the Chief Scientific Officer at Tango Therapeutics, Inc. from 2018 to 2023.
He worked at Novartis AG as a Senior Director from 2009 to 2015 and at Novartis Institutes of Biomedical Research as a Senior Director & Global Head-Oncology from 2003 to 2016.
He also worked as a Senior Scientist at Millennium Pharmaceuticals, Inc. Additionally, he holds a doctorate degree from the University of South Alabama, which he received in 1998, and an undergraduate degree from Fudan University, which he received in 1993.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
TANGO THERAPEUTICS, INC.
0.13% | 01/04/2023 | 135 887 ( 0.13% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Alan Huang
| Società | Posizione | Inizio |
|---|---|---|
Casdin Capital /Private Equity/
 Casdin Capital /Private Equity/ Investment ManagersFinance Casdin Capital /Private Equity/ (Casdin Capital) is a private equity/venture capital subsidiary of Casdin Capital LLC founded in 2012 by Eli Casdin. The firm is headquartered in New York. | Consultant / Advisor | 01/03/2021 |
Precedenti posizioni note di Alan Huang
| Società | Posizione | Fine |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 06/10/2023 |
Novartis Institutes of Biomedical Research
 Novartis Institutes of Biomedical Research BiotechnologyHealth Technology Novartis Institutes of Biomedical Research operates a pharmaceutical research organization. The private company is based in Emeryville. | Corporate Officer/Principal | 01/01/2016 |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Director/Board Member | 31/12/2015 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Formazione di Alan Huang
| University of South Alabama | Doctorate Degree |
| Fudan University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TANGO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Health Technology |
Casdin Capital /Private Equity/
Casdin Capital /Private Equity/ Investment ManagersFinance Casdin Capital /Private Equity/ (Casdin Capital) is a private equity/venture capital subsidiary of Casdin Capital LLC founded in 2012 by Eli Casdin. The firm is headquartered in New York. | Finance |
Novartis Institutes of Biomedical Research
Novartis Institutes of Biomedical Research BiotechnologyHealth Technology Novartis Institutes of Biomedical Research operates a pharmaceutical research organization. The private company is based in Emeryville. | Health Technology |
- Borsa valori
- Insiders
- Alan Huang
